Result: Risk Minimisation Materials for medicines starting with the letter F

Fabrazyme

Sanofi Genzyme

Fabrazyme (agalsidase beta) - Home Infusion HCP Manual - Risk Minimisation Information for Healthcare Professionals

The objective of this document is to provide guidance to healthcare professionals for the management of patients receiving Fabrazyme (agalsidase beta) at home. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

For Healthcare Professionals

Fabrazyme (agalsidase beta) - Home Infusion Patient Manual - Risk Minimisation Information for Patients

The objective of this document is to provide patients with guidance on how to receive Fabrazyme (agalsidase beta) at home. It is the responsibility of the treating physician to supply this material to patients only if the treating physician decides that the patient is eligible for home infusion treatment. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

For Healthcare Professionals

Fabrazyme (agalsidase beta)Home Infusion Patient Logbook- Risk Minimisation Information for Patients

For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

Femodene

Bayer plc

CHCs - Checklist for Prescribers

Combined Hormonal Contraceptives - checklist for prescribers

For Healthcare Professionals

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Femodene ED

Bayer plc

CHCs - Checklist for Prescribers

Combined Hormonal Contraceptives - checklist for prescribers

For Healthcare Professionals

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Femodette

Bayer plc

CHCs - Checklist for Prescribers

Combined Hormonal Contraceptives - checklist for prescribers

For Healthcare Professionals

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Fingolimod

Dr. Reddy's Laboratories (UK) Ltd

Fingolimod - Patients Information Booklet - for Patients

This patient booklet contains important things to remember about Fingolimod treatment for patients, parents and caregivers

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

This reminder card contains pregnancy-specific safety information about Fingolimod treatment

Fingolimod - Prescribers checklist - for Healthcare Professionals

This checklist outlines important points to remember before, during and after treatment

For Healthcare Professionals

Zentiva

Fingolimod Patient Card

Pregnancy Specific Patient Reminder Card

Fingolimod Patient Guide

Important things to remember about Fingolimod Zentiva 0.5 mg hard capsules treatment for patients, parents and caregivers

Fingolimod Prescribers Checklist

Important points to remember before, during and after treatment

Fintepla

Zogenix International Limited

Fintepla (fenfluramine) Patient and Caregiver Guide

IMPORTANT Fintepla (fenfluramine) Information About Fintepla For Patients And Caregivers

Fintepla (fenfluramine) Prescriber Guide

Fintepla (fenfluramine) Guide On Reducing The Risks Related to Medicines And Their Administration - Prescribers

For Healthcare Professionals

Flixabi

Biogen Biosimilars

Flixabi Patient Reminder Card

This Reminder Card contains important safety information that patients need to be aware of before and during treatment with Flixabi.